"Aldosterone Antagonism With Eplerenone Does Not Adversely Affect Plasma Glucose Levels in Patients With Diabetes Mellitus: Findings From a Post Hoc Analysis of the EPHESUS Trial" by Prakash Deedwania, MD

Presentation

Aldosterone Antagonism With Eplerenone Does Not Adversely Affect Plasma Glucose Levels in Patients With Diabetes Mellitus: Findings From a Post Hoc Analysis of the EPHESUS Trial

Department of Medicine

Prakash Deedwania, MD
Bertram Pitt, MD
Ravi V Desai, MD, Lehigh Valley Health Network
Marjan Mujib, MD, MPH
Inmaculada B Aban, PhD
John Vincent
Eva Turgonyi
Ali Ahmed, MD, MPH

Publication/Presentation Date

8-30-2010

Comments

European Heart Journal ( 2010 ) 31 ( Abstract Supplement ), 423-424

Disciplines

Cardiology,
Chemicals and Drugs,
Endocrinology, Diabetes, and Metabolism,
Medical Specialties and
Medicine and Health Sciences

Document Type

Poster

Citation Information

Deedwania, P., Pitt, B., Desai, R., Mujib, M., Aban, I., Vincent, J., Turgonyi, E., & Ahmed, A. (2010, August 28-September 1). Aldosterone antagonism with eplerenone does not adversely affect plasma glucose levels in patients with diabetes mellitus: Findings from a post hoc analysis of the EPHESUS trial. Poster presented at: The 2010 European Society of Cardiology Congress, Stockholm, Sweden.